J&J | JNJ - Sales Revenues

Stock Price
227.35
Daily Change
-0.44 -0.19%
Monthly
-6.24%
Yearly
45.45%
Q2 Forecast
222.63

J&J reported $24.1B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
AbbVie USD 15B 1.62B Mar/2026
Abbott USD 11.16B 300M Mar/2026
Amgen USD 9.9B 340M Dec/2025
AstraZeneca USD 15.29B 213M Mar/2026
Baxter International USD 2.97B 130M Dec/2025
Bayer EUR 11.44B 1.78B Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Biogen USD 2.25B 30M Mar/2026
Boston Scientific USD 5.2B 90M Mar/2026
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
CONMED USD 317M 56.2M Mar/2026
Cooper Companies USD 1.02B 41.1M Dec/2025
Dexcom USD 1.26B 50M Dec/2025
Edwards Lifesciences USD 1.65B 80M Mar/2026
Eli Lilly USD 19.3B 1.7B Dec/2025
Gilead Sciences USD 7.93B 130M Dec/2025
GlaxoSmithKline GBP 7.63B 991M Mar/2026
Globus Medical USD 826.4M 57.4M Dec/2025
Insulet USD 783.8M 77.5M Dec/2025
Integra LifeSciences USD 434.9M 32.84M Dec/2025
Intuitive Surgical USD 2.77B 100M Mar/2026
J&J USD 24.1B 500M Mar/2026
Medtronic USD 9B 39M Jan/2026
Merck USD 16.4B 880M Dec/2025
Merit Medical Systems USD 393.9M 9.7M Dec/2025
Novartis USD 13.11B 226M Mar/2026
Pfizer USD 17.58B 880M Dec/2025
Regeneron Pharmaceuticals USD 3.6B 280M Mar/2026
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.24B 60M Mar/2026
Stryker USD 7.2B 1.14B Dec/2025
Tandem Diabetes Care USD 290.4M 41.15M Dec/2025
Teva Pharmaceutical Industries USD 11.77B 2.86B Mar/2026
Vertex Pharmaceuticals USD 3.19B 110M Dec/2025
Zimmer Biomet Holdings USD 2.09B 150M Mar/2026
Zoetis USD 2.4B 0 Dec/2025